Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05013333 · ClinicalTrials.gov registry record · NA

AED 3 Post-Approval Study

A NA study of Cardiac Arrest, Out-Of-Hospital, sponsored by Zoll Medical Corporation.

Active
Registry status
NA
Development phase
38
Enrollment target
2
Study locations

NCT05013333 is a NA study of Cardiac Arrest, Out-Of-Hospital that is active but no longer recruiting, run by Zoll Medical Corporation. The registered enrollment target is 38 participants, below the 1,618-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05013333, a NA study of Cardiac Arrest, Out-Of-Hospital, is active but no longer recruiting, sponsored by Zoll Medical Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
2
Study locations

Study Summary

Demonstrate appropriate CPR sensor placement on pediatric and adult patients and demonstrate delivery of appropriate energy level of shocks to pediatric and adult patients.

Interventions

  • DEVICE AED 3 with Uni-padz

Study Locations (2)

New York

  • University at Buffalo - Buffalo
  • Colonie EMS - Latham

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2021-03-30
Est. Completion 2029-02-28
Phase NA

Sponsor

Zoll Medical Corporation

24 total trials

What the Registry Record Tells You About NCT05013333

The ClinicalTrials.gov registry entry for NCT05013333 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,618-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (98% lower). The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrest, Out-Of-Hospital appearing as the primary indexed condition, and to 1 intervention - of which AED 3 with Uni-padz is the first listed.

NCT05013333 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05013333 about?

NCT05013333 is a clinical study titled "AED 3 Post-Approval Study". Demonstrate appropriate CPR sensor placement on pediatric and adult patients and demonstrate delivery of appropriate energy level of shocks to pediatric and adult patients.

What is the current status of trial NCT05013333?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2021-03-30. Estimated completion is 2029-02-28.

What conditions does trial NCT05013333 study?

This clinical trial studies the following conditions: Cardiac Arrest, Out-Of-Hospital.

What interventions are being tested in trial NCT05013333?

The interventions under investigation include: AED 3 with Uni-padz (DEVICE).

Who is sponsoring clinical trial NCT05013333?

This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05013333 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrest, Out-Of-Hospital

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.